Chicken ovalbumin upstream promoter transcription factor, a transcriptional activator of HIV-1 gene expression in human brain cells. by Sawaya, B. (B E) et al.
Aunis and Evelyne Schaeffer
Bassel E. Sawaya, Olivier Rohr, Dominique
  
Human Brain Cells
Activator of HIV-1 Gene Expression in
Transcription Factor, a Transcriptional 
Chicken Ovalbumin Upstream Promoter
Molecular Genetics:
Nucleic Acids, Protein Synthesis, and
doi: 10.1074/jbc.271.38.23572
1996, 271:23572-23576.J. Biol. Chem. 
  
 http://www.jbc.org/content/271/38/23572Access the most updated version of this article at 
  
.JBC Affinity SitesFind articles, minireviews, Reflections and Classics on similar topics on the 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
  
 http://www.jbc.org/content/271/38/23572.full.html#ref-list-1
This article cites 40 references, 30 of which can be accessed free at




















Chicken Ovalbumin Upstream Promoter Transcription Factor, a
Transcriptional Activator of HIV-1 Gene Expression in Human
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Viral infection of the central nervous system by the
human immunodeficiency virus type 1 leads to a wide
range of neuropathological disorders. However, the mo-
lecular mechanisms governing transcription of the hu-
man immunodeficiency virus type 1 genome in brain
remain unclear. We have recently established that in
brain cells, proteins belonging to the steroid/thyroid/
retinoic acid receptor family bind to the 2352 to 2320
region of the long terminal repeat (LTR). Here, by su-
pershift experiments, we have identified chicken
ovalbumin upstream promoter transcription factor
(COUP-TF), an orphan member of this nuclear receptor
family, as one of the major proteins interacting with this
LTR site. Cotransfection studies revealed that COUP-TF
is able to dramatically activate LTR-directed gene tran-
scription in human oligodendroglioma but not in astro-
cytoma cells. This activation occurs through two mech-
anisms, depending on the LTR sequence. Moreover, in
neuronal cells COUP-TF and dopamine, a catecholamine
neurotransmitter, enhance LTR-directed transcription
by acting on the proximal LTR region. These results
reveal the importance of COUP-TF and the dopamine
signaling pathway as activators of human immunodefi-
ciency virus type 1 gene expression in brain.
The human central nervous system (CNS)1 is an important
target of the human immunodeficiency virus type 1 (HIV-1).
Viral infection of the brain leads to a wide range of neurological
complications (1, 2). A number of studies have revealed that
together with cells of the monocyte/macrophage lineage, neu-
ronal and glial cell infection underlies neuropathological dam-
age. Virus proteins and nucleic acids have been detected in
oligodendrocytes, astrocytes, and neurons (3–5).
HIV-1 gene expression is controlled by a combination of viral
and host cell transcription factors interacting with the long
terminal repeat (LTR) region (6–8). Besides differences in en-
velope sequences of the virus that influence the occurrence of
nervous system disease (9), the LTR region is also able to
contribute to HIV-1 cell type-specific expression. This was dem-
onstrated by transgenic mouse studies which revealed that the
LTR of neurotropic HIV-1 strains JR-FL and JR-CSF directs
gene expression in CNS neurons (10, 11); in contrast, the lym-
photropic LAI strain was unable to direct gene expression in
the CNS of transgenic mice (12, 13). These transgenic data
strongly suggest the importance of cellular transcription fac-
tors present in brain cells, different from those in non neural
cells.
Recent studies have focused on transcription factors that
regulate HIV-1 expression in brain cells. They have shown that
the activity of the HIV promoter is mediated by kB-regulatory
sequences of the LTR, through the action of the transcription
factor NF-kB, in both neurons (14, 15) and astrocytes (16).
Besides the kB-regulatory element, recent in vitro data have
highlighted the importance of an upstream-located regulatory
element. The nuclear receptor-responsive element (NRRE) ap-
pears to be the point of convergence of a complex network of
physiological signals that modulate HIV-1 gene expression.
This element contains binding sites for transcription factors
belonging to the steroid/thyroid/retinoic acid receptor super-
family as well as for nuclear receptors with unknown ligands,
such as Ear-3/COUP-TF (17–19). In non-CNS-derived cells
COUP-TF acts as a repressor of the retinoid response (19). In
brain cells, however, the action of nuclear receptors remains to
be investigated.
We have recently described (20) that the orphan nuclear
receptors COUP-TF/Ear3 (21–23) are present in three human
brain cell lines that are permissive to HIV-1 infection, oligo-
dendroglioma TC-620, astrocytoma U373-MG, and neuroblas-
toma SK-N-MC cells. A number of studies revealed that
COUP-TF may play a dual regulatory role and direct either
positive (24–26) or negative regulation of eukaryotic gene ex-
pression (25, 27–29) depending on the promoter and the cell
context. Here we have examined the role of COUP-TF on LTR-
directed gene expression in glial and neuronal cells. We have
analyzed both the lymphotropic LAI and the neurotropic JR-
CSF HIV-1 LTR. Our data demonstrate the importance of
COUP-TF as a potent transcriptional activator in oligodendro-
glioma cells. They reveal the action of the dopamine transduc-
tion pathway, which coupled to COUP-TF contributes to en-
hancement of HIV-1 gene transcription in neuronal cells.
MATERIALS AND METHODS
Construction of Plasmids—To generate LTR(JR-CSF)-CAT, 2283/
120 LTR-CAT, and 2159/120 LTR-CAT, the plasmid pSAFYre con-
taining the JR-CSF LTR (gift of Dr. J. Clements) was digested with,
respectively, EcoRV 1 BglII, EarI 1 BglII, and AvaI 1 BglII. The LTR
inserts were isolated, blunt-ended, and subcloned in the SmaI site of
pUC19-CAT0. To generate LTR(LAI)-CAT, 2283/180 LTR-CAT, and
2159/180 LTR-CAT, the plasmid pSV1b-CAT containing the LAI LTR
(gift of Dr. N. Israel) was digested with, respectively, BglII1HindIII,
EarI1HindIII, and AvaI1HindIII. The LTR inserts were blunt-ended
and subcloned in the SmaI site of pUC19-CAT0. The 268/129 LTR-
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CAT vector was constructed by subcloning in the SmaI site of pUC19-
CAT0 the BstNI-BstNI blunt-ended LTR insert. To construct the
LTRmut3-CAT vectors, site-directed mutagenesis was performed with
the mutant oligonucleotide 3Lmut: 59CCAGGGGTAAGATATCCA-
CAAAGCTTTG39. To construct the 3L/tk-CAT and 3Lmut/tk-CAT vec-
tors, the 3L and 3Lmut oligonucleotides were, respectively, subcloned
in the blunt-ended SalI site of pBLCAT2, containing the herpes simplex
virus thymidine kinase promoter in front of the CAT gene.
Cell Culture, Transfections, and CAT Assays—Human astrocytoma
U373-MG (ATCC HTB17) and neuroblastoma SK-N-MC cells (ATCC
HTB10) were grown in Dulbecco’s modified Eagle’s medium supple-
mented with 10% fetal calf serum and 10 mM HEPES. The medium of
neuroblastoma SK-N-MC cells was supplemented with nonessential
amino acids. Jurkat T cells were grown in RPMI 1640 with 10% fetal
calf serum and 10 mM HEPES. All these cell lines were cultured in the
presence of penicillin-streptomycin (100 units/ml). Human oligodendro-
glioma TC-620 cells (30) were grown in Iscove’s medium containing 10%
non-heat-inactivated fetal calf serum and 1% gentamicin.
Cells (106) were either transfected by the calcium phosphate precip-
itation method with 1 pmol of plasmid reporter DNA or cotransfected
with reporter DNA (1 pmol) and the COUP-TF expression vector (0.5
pmol), as described previously (25). Each transfection was done in
duplicate and repeated a minimum of three separate times with at least
two different plasmid preparations. Cell extracts were prepared 48 h
after transfection, and CAT assays were performed as described previ-
ously (25); reaction mixtures containing 5, 10, or 20 mg of protein were
incubated at 37 °C for 1, 2, or 2 h for, respectively, oligodendroglioma,
astrocytoma, and neuroblastoma cells.
Electrophoretic Mobility Shift Assays—Nuclear proteins were ex-
tracted from at least 108 cells, as described previously (31), or were
prepared from a small number of transfected cells (5 3 106) according to
the procedure of Andrews and Faller (32). Protein-DNA binding reac-
tions were performed with 5 mg of nuclear extracts in a buffer contain-
ing 1 ng of 32P-59-end-labeled oligonucleotide, 1 mg of poly(dI-dC), 50 ng
of sonicated salmon sperm DNA, 10 mM MgCl2, 25 mM KCl, 1 mM
dithiothreitol, 12.5 mM HEPES, pH 7.8, 10% glycerol, 0.05% Nonidet
P-40. Mixtures were incubated for 15 min at 4 °C, and protein-DNA
complexes were analyzed by electrophoresis on a 6% polyacrylamide gel
in 0.25 3 Tris-buffered EDTA. For supershift assays, antibodies di-
rected against COUP-TF (gift of Dr. M. J. Tsai, Baylor College of
Medicine, Houston, TX) or normal rabbit serum were mixed with nu-
clear proteins for 3 h at 4 °C before addition of the probe.
RESULTS AND DISCUSSION
COUP-TF Present in Brain Cells Binds to the Nuclear Recep-
tor-responsive Element of the HIV-1 LTR—To examine the na-
ture of the proteins interacting with the NRRE located between
nucleotides 2356 and 2320 of the LTR, gel mobility supershift
assays were performed with nuclear proteins isolated from
three human brain cell lines, oligodendroglioma TC-620, astro-
cytoma U373-MG, and neuroblastoma SK-N-MC cells, using
the 3L oligonucleotide corresponding to the NRRE sequence
(Fig. 1). We have previously shown that proteins forming com-
plexes C1 to C3 belong to the nuclear receptor family, while
proteins forming the less specific complex C4 do not belong to
this superfamily (20). Complexes C1 to C4 were detected in all
three cell lines; the relative amount of each complex varied
slightly from one extraction to the next and also depended on
the method of nuclear extract preparation (31, 32). With the
rapid extraction method, a nonspecific complex appeared with
SN-N-MC proteins. The results of the supershift experiments
indicate that the COUP-TFs species do form the majority of the
DNA-protein complexes C1, C3, and C39 (Fig. 1). These findings
reveal that within human brain cells, COUP-TFs appear as the
major nuclear protein species interacting with the nuclear re-
ceptor-responsive element.
Functional Role of COUP-TF on LTR-directed HIV-1 Gene
Transcription in Brain Cells—The three glial and neuronal cell
lines were transfected with a LTR-CAT reporter vector, con-
taining the chloramphenicol acetyltransferase (CAT) gene un-
der the control of the LTR region from either the neurotropic
JR-CSF or the lymphotropic LAI HIV-1 strain. We used the
LTR region from the CNS-derived JR-CSF HIV-1 isolate (33)
since, unlike the LTR of the LAI isolate, it was found to direct
gene expression in the CNS of transgenic mice (10). The results
presented in Fig. 2 demonstrate the cell type-specific activity of
COUP-TF. In oligodendroglioma TC-620 cells, LTR-driven CAT
expression was dramatically stimulated 9–10-fold. The excep-
tional magnitude of this stimulation has never been reported
for COUP-TF. This interesting result indicates that COUP-TF
functions as a potent HIV-1 transcriptional activator in TC-620
cells. In contrast, in astrocytoma and neuronal cells, COUP-TF
was unable by itself to affect LTR-driven transcription (Fig. 2).
Dopamine, a catecholamine neurotransmitter, has been de-
scribed to activate COUP-TF by a phosphorylation-mediated
event, resulting from dopamine stimulation of cell surface re-
ceptors (34). We therefore investigated the possibility that do-
pamine might modulate LTR-driven transcription. Treatment
of neuronal SK-N-MC cells with 100 mM dopamine resulted in a
weak increase in LTR-driven CAT activity over untreated cells.
However, overexpression of COUP-TF combined with dopa-
mine treatment elicited a 3-fold stimulation of LTR-directed CAT
activity (Fig. 2). Similar results were obtained with the LTR of
the LAI and JR-CSF HIV-1 strains. Dopamine treatment of
TC-620 and U373-MG cells in similar conditions did not change
LTR-directed CAT activity. These findings indicate that specif-
ically in neuronal cells, HIV-1 gene transcription is enhanced
by COUP-TF following activation of the dopamine pathway. We
found that this activation was reversible by the addition of the
selective D1 receptor antagonist SCH23390 and was not af-
fected by sulpiride, a D2 antagonist (results not shown).
To compare the transfection efficiencies of the COUP-TF
vector in the different cell lines, we performed gel retardation
assays using the 3L probe and nuclear extracts from trans-
FIG. 1. COUP-TF binding activity to the 2352/2324 LTR site of
HIV-1 in human neuronal and glial cells. Nuclear protein extracts
(5 mg) were assayed by gel retardation assay with 1 ng of 32P-end-
labeled 3L oligonucleotide probe (lanes 2). The specific DNA-protein
complexes C1, C2, C3, C39, C4, and the nonspecific complex NS are
indicated, as described previously (20). For supershift assays, 1 ml of
COUP-TF antiserum (lanes COUP) or of nonimmune serum (lanes NIS)
was mixed with nuclear proteins 3 h before the addition of the 3L probe.
The sequence of the 3L synthetic oligonucleotide is indicated.
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fected or dopamine-treated cells (Fig. 3). In the presence of
COUP-TF, complexes C3 and C39 were strongly increased in
glial but not in neuronal cells. This result indicates that the
differences in trans-activation in oligodendroglioma and neu-
ronal cells are due to different transfection efficiencies of the
COUP-TF vector. Dopamine treatment increased the binding of
COUP-TF to the NRRE site in complexes C3 and C39 formed
with glial proteins, suggesting that a direct phosphorylation
event of COUP-TF enhances its binding ability (Fig. 3). These
data suggest that in TC-620 cells, high COUP-TF overexpres-
sion results in high binding and thus, to a optimal level of
trans-activation, which is unaffected by dopamine. In contrast,
in SK-N-MC cells, a low level of COUP-TF overexpression
correlates with a low level of trans-activation, which is stimu-
lated, via phosphorylation, by dopamine-induced increased
binding. Surprisingly, such an enhanced binding on the NRRE
site was not detected in Fig. 3. It therefore appeared essential
to examine whether the NRRE element was involved in the
COUP-TF- and dopamine-induced transcriptional stimulation.
Elements of the HIV-1 LTR Involved in COUP-TF-induced
Transcriptional Stimulation in TC-620 Cells—To define the
molecular mechanisms that control COUP-TF-induced tran-
scriptional stimulation, we first analyzed the role of the nu-
clear receptor-responsive element. The NRRE sequence was
inactivated within the LTR by site-directed mutagenesis, using
the 3Lmut oligonucleotide. We tested by gel shift assays that
3Lmut was unable to bind COUP-TF. Transfection of the mu-
tant constructs 2 and 7 (Fig. 4a) in TC-620 cells resulted in a
3-fold decrease in COUP-TF-induced CAT stimulation (Fig.
4b); this result confirmed the importance of the NRRE se-
quence. Similarly, the linkage of the NRRE sequence to the
heterologous thymidine kinase promoter in the 3L/tk-CAT vec-
tor could confer COUP-TF responsiveness. The 3L/tk-CAT vec-
tor led to a 3-fold increase in CAT activity, while the basal
FIG. 3. Analysis of COUP-TF expression in transfected glial
and neuronal cells. Gel retardation assays were performed with the
3L probe, and nuclear proteins were extracted according to the rapid
procedure (32) from cells treated with 100 mM dopamine (Dop) for 24 h
and/or transfected with COUP-TF for 48 h. Only the retarded DNA-
protein complexes are shown.
FIG. 2. Functional effects of
COUP-TF and dopamine on the HIV-1
LTR-driven transcription in human
neuronal and glial cells. Top, histo-
grams show the CAT activities expressed
relative to the value obtained with the
LTR(JR-CSF)-CAT reporter vector in
each cell type, in the presence or absence
of the COUP-TF expression vector. After
transfection (24 h), cells were treated
with 100 mM dopamine as indicated and
collected 48 h after transfection for deter-
mination of CAT activity. At least five
separate transfections were performed in
duplicate with different plasmid prepara-
tions. Bottom, one typical CAT assay per-
formed with 15 mg of cell extracts and 2 h
of incubation at 37 °C.
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activity of the control pBLCAT2 and the mutant 3Lmut/tk-CAT
vectors was not modified (results not shown). These results
clearly indicate that the 3L (or NRRE) sequence is responsible
for mediating, at least in part, the COUP-TF action.
However, the mutation of the NRRE site did not completely
abolish the COUP-TF-induced activation. To delineate the LTR
sequences responsible for this residual activation, we tran-
fected a series of LTR-CAT vectors containing 59 deletions of
the LTR (Fig. 4a). Surprisingly, the experiments revealed that
the 268/129 LTR region (Fig. 4, constructs 5 and 10) was able
to promote a basal level of transcription similar to that of the
entire LTR. This interesting finding indicates that in TC-620
cells, only two Sp1 sites and the TATA box region are sufficient
to function as a minimal promoter. In the LAI series, the 3-fold
residual COUP-TF-induced stimulation was abolished by re-
moval of sequences located between base pairs 2159 and 268
(Fig. 4b, constructs 4 and 5). This region contains the binding
site of the NF-kB transcription factor (12). These data indicate
that the action of COUP-TF on the LAI LTR is mediated mostly
through direct interactions with the NRRE site, and to a lesser
extent by cross-coupling interactions with downstream-located
factors. In contrast, in the JR-CSF series, removal of LTR
sequences from base pairs 2283 to 2159 (construct 9) and to
268 (construct 10) led to a stepwise decrease in the COUP-TF-
induced stimulation. We recently showed that the 2283 to
2159 region contains a binding site for the transcription factor
AP-1 specifically in the JR-CSF and not in the LAI LTR (20).
These results suggest that the action of COUP-TF on the JR-
CSF LTR is mediated not only by direct binding to the NRRE
sequence but also by cross-coupling interactions with down-
stream-located proteins, such as AP-1 and NF-kB.
Elements of the HIV-1 LTR Involved in COUP-TF- and Do-
pamine-induced Stimulation in SK-N-MC Cells—A similar de-
letion analysis performed in SK-N-MC cells showed that the
truncated LTR regions, including the minimal 268/129 region
were responsive to the combined action of COUP-TF and do-
pamine, since a 2–3-fold stimulation was detected (Fig. 4c). As
a control, COUP-TF and dopamine were unable to induce any
CAT activity of the pUC-CAT vector (results not shown). These
surprising findings indicate that the NRRE sequence is not
involved in the transcriptional activation mediated by
COUP-TF and dopamine. Recent reports indicated that the
thyroid hormone receptor T3R, another member of the nuclear
receptor superfamily, interacts with several sites in the proxi-
mal promoter spanning the Sp1 and NF-kB elements (35) or
overlapping the Sp1 sites within the 274/250 region (36).
However our findings differ from those reported with T3R,
since the minimal 268/129 COUP-TF- and dopamine-respon-
sive region contains only two Sp1 sites and the TATA region.
They suggest that the action of COUP-TF combined with do-
pamine-induced phosphorylation events are likely to be medi-
ated through interactions with components of the basal tran-
scription machinery. In vitro studies have demonstrated
interactions between COUP-TF and the basal transcription
factor TFIIB (37). Further investigations are nevertheless re-
quired to establish whether such interactions are relevant to
the in vivo situation. Similarly, in vivo and in vitro experiments
have demonstrated the ability of several nuclear receptors,
including thyroid hormone receptor b (38), vitamin D receptor
(39, 40), and retinoid X receptor (41), to interact with TFIIB.
In conclusion, our results establish the essential and new
role of COUP-TF as a cell type-specific transcriptional activator
of LTR-directed HIV-1 gene expression in brain. These data
reveal the remarkable diverse mechanisms by which COUP-TF
enhances viral gene transcription. This orphan nuclear recep-
tor is able to exert a major effect on distinct HIV-1 strains in
different brain cells types. In oligodendrocytes, this transcrip-
tion factor is able to dramatically stimulate HIV-1 gene tran-
FIG. 4. Analysis of COUP-TF interactions with the LTR derived from the lymphotropic LAI and the neurotropic JR-CSF HIV-1
strains. a, plasmid constructs used in transient expression assays. The LTR region of the LAI and JR-CSF HIV-1 strains was mutated within the
NRRE site or 59-end deleted. b, expression of CAT activity in TC-620 cells transfected with the LTR-CAT constructs, either alone (M) or in the
presence of the COUP-TF expression vector (f). CAT activities are expressed relative to that of construct 1 (LAI series) and 6 (JR-CSF series) taken
as 1. Numbers in parentheses indicate the fold stimulation induced by COUP-TF. c, expression of CAT activity in SK-N-MC cells, transfected with
the LTR-CAT constructs (M) and the COUP-TF expression vector followed by 100 mM dopamine treatment 24 h after transfection (f). CAT activities
are expressed as in b.
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scription, either by direct interactions with its NRRE target
site or, depending on the LTR sequence, by cross-coupling
interactions with downstream-located proteins. In neuronal
cells, where COUP-TF is inactive by itself, HIV-1 appears to
couple COUP-TF and the dopamine signal transduction path-
way with the general cellular transcription machinery. Since
dopamine antagonists appear able to reverse the dopamine-
induced stimulation, they could provide a way of limiting
HIV-1 activation in neuronal cells.
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